Ying Shang

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

2017-2021 Karolinska Institutet, Ph.D
2014-2016 Karolinska Institutet, MSc.
2009-2014 Shandong University, Medical Degree

Forskningsbeskrivning

My research mainly focuses on risk factors and clinical prognosis of chronic
liver disease, and currently work as part of the Hagström group at the
Department of Medicine, Huddinge (https://ki.se/en/medh/hagstrom-group [1]).
Other research interests involve the epidemiology of diabetes, metabolic
syndrome in general population and certain patients groups.
[1] https://ki.se/en/medh/hagstrom-group

Artiklar

Journal article: HEPATOLOGY. 2024

Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction-associated steatotic liver disease.

Shang Y; Akbari C; Dodd M; Zhang X; Wang T; Jemielita T; Fernandes G; Engel SS; Nasr P; Vessby J; Rorsman F; Kechagias S; Stål P; Ekstedt M; Hagström H
Journal article: GUT. 2024;:gutjnl-2024-333074

Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease

Zhou X-D; Kim SU; Yip TC-F; Petta S; Nakajima A; Tsochatzis E; Boursier J; Bugianesi E; Hagstrom H; Chan WK; Romero-Gomez M; Calleja JL; de Ledinghen V; Castera L; Sanyal AJ; Goh GB-B; Newsome PN; Fan J; Lai M; Fournier-Poizat C; Lee HW; Wong GL-H; Armandi A; Shang Y; Pennisi G; Llop E; Yoneda M; de Saint-Loup M; Canivet CM; Lara-Romero C; Gallego-Duran R; Asgharpour A; Teh KK-J; Mahgoub S; Chan MS-W; Lin H; Liu W-Y; Targher G; Byrne CD; Wong VW-S; Zheng M-H
Journal article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024;:S1542-3565(24)00679-7

Biomarkers for Prediction of Alcohol-Related Liver Cirrhosis: A General Population-Based Swedish Study of 537,250 Individuals.

Jakobsson G; Talbäck M; Hammar N; Shang Y; Hagström H
Journal article: LIVER INTERNATIONAL. 2024

Persons with metabolic dysfunction-associated steatotic liver disease are at increased risk of severe depression

Astrom H; Shang Y; Hagstrom H; Wester A
Article: DIABETES CARE. 2024;47(6):978-985

Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes.

Shang Y; Grip ET; Modica A; Skröder H; Ström O; Ntanios F; Gudbjörnsdottir S; Hagström H
Article: LIVER INTERNATIONAL. 2024;44(5):1253-1264

Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD

Yang W; Ebrahimi F; Romeo S; Holmer M; Vessby J; Ekstedt M; Ludvigsson JF; Shang Y; Hagstrom H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024;22(5):1048-1057.e2

Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis

Nasr P; Wester A; Ekstedt M; Strandberg R; Kechagias S; Shang Y; Widman L; Hagstrom H
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2024;331(15):1287-1297

Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease

Lin H; Lee HW; Yip TC-F; Tsochatzis E; Petta S; Bugianesi E; Yoneda M; Zheng M-H; Hagstrom H; Boursier J; Calleja JL; Goh GB-B; Chan W-K; Gallego-Duran R; Sanyal AJ; de Ledinghen V; Newsome PN; Fan J-G; Castera L; Lai M; Harrison SA; Fournier-Poizat C; Wong GL-H; Pennisi G; Armandi A; Nakajima A; Liu W-Y; Shang Y; de Saint-Loup M; Llop E; Teh KK-J; Lara-Romero C; Asgharpour A; Mahgoub S; Chan MS-W; Canivet CM; Romero-Gomez M; Kim SU; Wong VW-S
Article: GUT. 2024;73(5):835-843

Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes

Wester A; Shang Y; Grip ET; Matthews AA; Hagstrom H
Article: ADDICTION. 2024;119(4):706-716

Disentangling the contributions of alcohol use disorder and alcohol-related liver disease towards dementia: A population-based cohort study

Zhao S; Widman L; Hagstrom H; Shang Y
Article: JHEP REPORTS. 2024;6(2):100915

Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD

Akbari C; Dodd M; Stal P; Nasr P; Ekstedt M; Kechagias S; Vessby J; Rorsman F; Zhang X; Wang T; Jemielita T; Fernandes G; Engel SS; Hagstrom H; Shang Y
Journal article: GASTRO HEP ADVANCES. 2024;3(6):783-792

Lower Incidence of HCC and Other Major Adverse Liver Outcomes in People Living With HIV and Chronic Liver Disease

Michel M; Hagström H; Widman L; Nowak P; Shang Y; Schattenberg JM; Wester A
Article: JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES. 2024;79(1):glad111

Associations Between Mid- to Late-Life Body Mass Index and Chronic Disease-Free Survival: A Nationwide Twin Study

Guo J; Dove A; Shang Y; Marseglia A; Johnell K; Rizzuto D; Xu W
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(13):3336-3345.e2

Secondary Prevention of Esophageal Variceal Bleeding Is Often Imperfect: A National, Population-Based Cohort Study of 3592 Patients

Hagstroem H; Shang Y; Tapper EB; Wester A; Widman L
Article: JOURNAL OF HEPATOLOGY. 2023;79(6):1374-1384

Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study

Ebrahimi F; Hagstrom H; Sun J; Bergman D; Shang Y; Yang W; Roelstraete B; Ludvigsson JF
Article: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2023;11(9):852-860

Four-fold increased mortality rate in patients with Wilson's disease: A population-based cohort study of 151 patients

Aberg F; Shang Y; Strandberg R; Wester A; Widman L; Hagstrom H
Article: HEPATOLOGY COMMUNICATIONS. 2023;7(11):e0238

Risk of injuries before and after a diagnosis of cirrhosis: A population-based cohort study

Shang Y; Shen Q; Tapper EB; Wester A; Hagstrom H
Article: ANNALS OF ONCOLOGY. 2023;34(11):1015-1024

Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial

Nilsson K; Klevebro F; Sunde B; Rouvelas I; Lindblad M; Szabo E; Halldestam I; Smedh U; Wallner B; Johansson J; Johnsen G; Aahlin EK; Johannessen H-O; von Doebeln GA; Hjortland GO; Wang N; Shang Y; Borg D; Quaas A; Bartella I; Bruns C; Schroeder W; Nilsson M
Article: LIVER INTERNATIONAL. 2023;43(10):2142-2152

Risk of infections in non-alcoholic fatty liver disease: A nationwide population-based cohort study

Shang Y; Widman L; Ebrahimi F; Ludvigsson JF; Hagstrom H; Wester A
Article: HEPATOLOGY COMMUNICATIONS. 2023;7(10):e0279

Time trends in mortality and life expectancy in 22,658 patients hospitalized with alcohol-associated cirrhosis: A nationwide cohort study

Wester A; Shang Y; Stal P; Hagstrom H
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s302-s303

Secondary prevention of variceal bleeding is often imperfect: a national, population-based cohort study of 5,018 patients

Hagstrom H; Shang Y; Tapper E; Wester A; Widman L
Article: ALZHEIMERS & DEMENTIA. 2023;19(3):821-830

Cardiometabolic multimorbidity accelerates cognitive decline and dementia progression

Dove A; Marseglia A; Shang Y; Grande G; Vetrano DL; Laukka EJ; Fratiglioni L; Xu W
Article: JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES. 2023;78(1):143-150

Association Between Late-Life Weight Change and Dementia: A Population-based Cohort Study

Guo J; Marseglia A; Shang Y; Dove A; Grande G; Fratiglioni L; Xu W
Article: HEPATOLOGY. 2022;76(5):1495-1505

Risk of cardiovascular disease and loss in life expectancy in NAFLD

Shang Y; Nasr P; Widman L; Hagstrom H
Article: JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES. 2022;77(10):2093-2101

Healthy Behaviors, Leisure Activities, and Social Network Prolong Disability-Free Survival in Older Adults With Diabetes

Shang Y; Wu W; Dove A; Guo J; Welmer A-K; Rizzuto D; Fratiglioni L; Xu W
Article: NEUROLOGY. 2022;99(6):e574-e582

Nonalcoholic Fatty Liver Disease and Risk of Dementia A Population-Based Cohort Study

Shang Y; Widman L; Hagstrom H
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2022;57(8):978-983

Cohort profile: decoding the epidemiology of liver disease in Sweden (DELIVER)

Hagstrom H; Shang Y; Wester A; Widman L
Journal article: ALZHEIMERS & DEMENTIA. 2021;17(S10)

Cardiometabolic multimorbidity accelerates cognitive decline and progression to dementia in older adults

Dove A; Marseglia A; Shang Y; Vetrano DL; Grande G; Laukka EJ; Fratiglioni L; Xu W
Article: JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES. 2021;76(12):2275-2283

Metabolic Syndrome Is Associated With Poor Cognition: A Population-Based Study of 70-Year-Old Adults Without Dementia

Marseglia A; Darin-Mattsson A; Skoog J; Ryden L; Hadarsson-Bodin T; Kern S; Sterner TR; Shang Y; Zettergren A; Westman E; Skoog I
Article: ALZHEIMERS & DEMENTIA. 2021;17(11):1769-1778

The impact of diabetes on cognitive impairment and its progression to dementia

Dove A; Shang Y; Xu W; Grande G; Laukka EJ; Fratiglioni L; Marseglia A
Article: AGE AND AGEING. 2021;50(5):1666-1674

Individual changes in anthropometric measures after age 60 years: a 15-year longitudinal population-based study

Guo J; Shang Y; Fratiglioni L; Johnell K; Welmer A-K; Marseglia A; Xu W
Article: AGE AND AGEING. 2021;50(5):1657-1665

Association of life satisfaction with disability-free survival: role of chronic diseases and healthy lifestyle

Wu W; Shang Y; Calderon-Larranaga A; Rizzuto D; Saadeh M; Dove A; Pan K-Y; Xu W
Article: CLINICAL NUTRITION. 2021;40(8):4838-4844

The Nordic prudent diet prolongs survival with good mental and physical functioning among older adults: The role of healthy lifestyle

Wu W; Shang Y; Dove A; Guo J; Calderon-Larranaga A; Rizzuto D; Xu W
Article: JHEP REPORTS. 2021;3(2):100218

Non-alcoholic fatty liver disease does not increase dementia risk although histology data might improve risk prediction

Shang Y; Nasr P; Ekstedt M; Widman L; Stal P; Hultcrantz R; Kechagias S; Hagstrom H
Article: DIABETES CARE. 2021;44(3):690-698

Not Only Diabetes but Also Prediabetes Leads to Functional Decline and Disability in Older Adults

Shang Y; Fratiglioni L; Vetrano DL; Dove A; Welmer A-K; Xu W
Article: AGE AND AGEING. 2021;50(2):480-487

Can health behaviours prolong survival and compress the period of survival with the disability? A population-based cohort study

Wu W; Xu W; Englund S; Shang Y; Pan K-Y; Rizzuto D
Article: ALZHEIMERS & DEMENTIA. 2021;17(2):191-204

Shared risk and protective factors between Alzheimer's disease and ischemic stroke: A population-based longitudinal study

Wang R; Qiu C; Dintica CS; Shang Y; Larranaga AC; Wang H-X; Xu W
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S10)

Type 2 diabetes and cardiovascular disease increase the risk of cognitive impairment and accelerate the progression to dementia in Swedish older adults

Dove A; Shang Y; Grande G; Laukka EJ; Fratiglioni L; Xu W; Marseglia A
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2020;21(10):1458-1463.e2

Role of Cognitive Impairment, Physical Disability, and Chronic Conditions in the Association of Sleep Duration With All-Cause Mortality Among Very Old Adults

Cao Z; Dintica C; Shang Y; Cheng Y; Li S; Yang H; Sun L; Xu W; Wang Y
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2020;9(18):e017346

Association of Cardiovascular Risk Burden With Risk and Progression of Disability: Mediating Role of Cardiovascular Disease and Cognitive Decline

Cui K; Song R; Xu H; Shang Y; Qi X; Buchman AS; Bennett DA; Xu W
Article: ALZHEIMERS & DEMENTIA. 2020;16(7):1003-1012

Association of diabetes with stroke and post-stroke dementia: A population-based cohort study

Shang Y; Fratiglioni L; Marseglia A; Plym A; Welmer A-K; Wang H-X; Wang R; Xu W
Article: AGING-US. 2020;12(9):8536-8548

The relation of poor mastication with cognition and dementia risk: a population-based longitudinal study

Dintica CS; Marseglia A; Wardh I; Elgestad PS; Rizzuto D; Shang Y; Xu W; Pedersen NL
Article: ALZHEIMERS & DEMENTIA. 2020;16(2):316-325

Leisure activity and social integration mitigate the risk of dementia related to cardiometabolic diseases: A population-based longitudinal study

Wang Z; Marseglia A; Shang Y; Dintica C; Patrone C; Xu W
Article: JOURNAL OF INTERNAL MEDICINE. 2019;286(3):326-340

Natural history of prediabetes in older adults from a population-based longitudinal study

Shang Y; Marseglia A; Fratiglioni L; Welmer A-K; Wang R; Wang H-X; Xu W
Visa fler

Alla övriga publikationer

Letter: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024;22(3):670

Secondary Prevention of Esophageal Variceal Bleeding: Still a Long Way to Go Reply

Hagstrom H; Shang Y; Tapper EB; Wester A; Widman L
Letter: GUT. 2024;:gutjnl-2023-331331

Cause of death by fibrosis stage in 959 patients with biopsy-proven NAFLD

Shang Y; Akbari C; Dodd M; Nasr P; Vessby J; Rorsman F; Kechagias S; Stal P; Ekstedt M; Hagstrom H
Letter: JOURNAL OF HEPATOLOGY. 2024;56(2):e76-e77

99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical

Hagstroem H; Vessby J; Ekstedt M; Shang Y
Letter: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(5):1359-1361.e2

Statins Are Underused in Women With NAFLD After Cardiovascular Events Compared With Matched Control Subjects

Shang Y; Hagstrom H
Editorial comment: HEPATOLOGY. 2023;77(2):350-351

Less is more? Screening for steatosis in older populations

Hagstrom H; Shang Y
Thesis / dissertation: 2021

How can older adults combat diabetes to achieve a longer and healthier life?

Shang, Ying
Letter: JOURNAL OF INTERNAL MEDICINE. 2019;286(6):728-729

Clarifications on blood pressure measurements and the validity of the conclusions

Shang Y; Xu W

Anställningar

Biträdande Lektor, Medicin, Huddinge, Karolinska Institutet, 2024-2029

Examina och utbildning

Medicine Doktorsexamen, Institutionen för neurobiologi, vårdvetenskap och samhälle, Karolinska Institutet, 2021
Medicine Masterexamen, Karolinska Institutet, 2016

Om mig

Forskningsbeskrivning

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI